✦ LIBER ✦

Phase II study of oral S-1 with irinotecan and bevacizumab (SIRB) as first-line therapy for patients with metastatic colorectal cancer

✍ Scribed by Yasuhide Yamada, Tatsuro Yamaguchi, Hiroshi Matsumoto, Yasushi Ichikawa, Ayumu Goto, Ken Kato, Tetsuya Hamaguchi, Yasuhiro Shimada

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Phase I/II study of oxaliplatin with ora

✍ Yamada, Y; Tahara, M; Miya, T; Satoh, T; Shirao, K; Shimada, Y; Ohtsu, A; Sasaki 📂 Article 📅 2008 🏛 Nature Publishing Group 🌐 English ⚖ 118 KB

3068 POSTER Capecitabine + irinotecan +

✍ S. Beslija; M. Banjin; S. Jungic; N. Obralic; G. Kecman-Malcic; I. Rakita; B. Sa 📂 Article 📅 2007 🏛 Elsevier Science 🌐 English ⚖ 80 KB

Phase II study of UFT with leucovorin an

✍ Delord, J-P; Bennouna, J; Artru, P; Perrier, H; Husseini, F; Desseigne, F; Franç 📂 Article 📅 2007 🏛 Nature Publishing Group 🌐 English ⚖ 108 KB

A phase II study of weekly irinotecan as

✍ Hideki Ueno; Takuji Okusaka; Akihiro Funakoshi; Hiroshi Ishii; Kenji Yamao; Osam 📂 Article 📅 2006 🏛 Springer 🌐 English ⚖ 328 KB

Bevacizumab in combination with biweekly

✍ García-Alfonso, P; Muñoz-Martin, A J; Alvarez-Suarez, S; Jerez-Gilarranz, Y; Rie 📂 Article 📅 2010 🏛 Nature Publishing Group 🌐 English ⚖ 243 KB

Phase II study of FOLFOX, bevacizumab an

✍ Meyerhardt, J.; Stuart, K.; Fuchs, C.; Zhu, A.; Earle, C.; Bhargava, P.; Blaszko 📂 Article 📅 2007 🏛 Oxford University Press 🌐 English ⚖ 84 KB